
- Volume 0 0
LUNG CANCER ORGANIZATION RELEASES EDUCATIONAL RESOURCES
Recent news has indicatedthat more women are dyingfrom lung cancer, comparedwith any type of cancer. As aresult, the National LungCancer Partnership has developed 2 educational tools for patientsdiagnosed with lung cancer.
The booklet, ?Living with a Diagnosis of Lung Cancer,? is available inquantity to physician practices. It helps those recently diagnosed withlung cancer to answer basic questions about what the diagnosismeans, who may be part of the cancer care team, and what theirtreatments may entail.
The patient-education video is designed to clarify the clinical-trialprocess by showing lung-cancer patients? personal experiences withthem. Stories of Strength: Making the Decision to Enter a Lung CancerClinical Trial discusses the pros and cons of joining a clinical trial andwhy lung-cancer patients should consider this option as part of theirtreatment plan. The video depicts 4 lung-cancer survivors who choseto participate in clinical trials and details what it can involve and howit affected the treatments and outcomes of these patients. The educationalresource also is available in quantity and is free.
The booklet and the video can be obtained at www.NationalLungCancerPartnership.org or by sending an e-mail with contact informationand the quantity to info@NationalLungCancerPartnership.org.
Articles in this issue
over 18 years ago
Calming the Symptoms of Menopauseover 18 years ago
Zoster Vaccineover 18 years ago
pharmacy TECHNOLOGY productsover 18 years ago
health-systems PRODUCT newsover 18 years ago
can you READ these Rxs?over 18 years ago
can you READ these Rxs?over 18 years ago
Generic Times Product Newsover 18 years ago
compounding HOTLINEover 18 years ago
Human HRT Leads Compounding Renaissanceover 18 years ago
Prescription-overdose Deaths Surpass Car-accident DeathsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.












































































































































































































